155 related articles for article (PubMed ID: 2476629)
1. Alinidine reduces the incidence of ischemic ventricular fibrillation in a conscious canine model, a protective effect antagonized by overdrive atrial pacing.
Uprichard AC; Chi LG; Lynch JJ; Driscoll EM; Frye JW; Lucchesi BR
J Cardiovasc Pharmacol; 1989 Sep; 14(3):475-82. PubMed ID: 2476629
[TBL] [Abstract][Full Text] [Related]
2. Celiprolol does not protect against ventricular tachycardia or sudden death in the conscious canine: a comparison with pindolol in assessing the role of intrinsic sympathomimetic activity.
Uprichard AC; Chi LG; Kitzen JM; Lynch JJ; Frye JW; Lucchesi BR
J Pharmacol Exp Ther; 1989 Nov; 251(2):571-7. PubMed ID: 2572693
[TBL] [Abstract][Full Text] [Related]
3. Electropharmacology of the bradycardic agents alinidine and zatebradine (UL-FS 49) in a conscious canine ventricular arrhythmia model of permanent coronary artery occlusion.
Aidonidis I; Brachmann J; Rizos I; Zacharoulis A; Stavridis I; Toutouzas P; Kübler W
Cardiovasc Drugs Ther; 1995 Aug; 9(4):555-63. PubMed ID: 8547205
[TBL] [Abstract][Full Text] [Related]
4. Protection against programmed electrical stimulation-induced ventricular tachycardia and sudden cardiac death by NE-10064, a class III antiarrhythmic drug.
Black SC; Butterfield JL; Lucchesi BR
J Cardiovasc Pharmacol; 1993 Dec; 22(6):810-8. PubMed ID: 7509898
[TBL] [Abstract][Full Text] [Related]
5. Prostacyclin prevents ventricular fibrillation in a canine model of sudden cardiac death.
Fiedler VB; Mardin M
Basic Res Cardiol; 1986; 81(1):40-53. PubMed ID: 3521579
[TBL] [Abstract][Full Text] [Related]
6. Antifibrillatory efficacy of long-term tedisamil administration in a postinfarcted canine model of ischemic ventricular fibrillation.
Friedrichs GS; Abreu JN; Driscoll EM; Borlak J; Lucchesi BR
J Cardiovasc Pharmacol; 1998 Jan; 31(1):56-66. PubMed ID: 9456278
[TBL] [Abstract][Full Text] [Related]
7. Hypothyroidism renders protection against lethal ventricular arrhythmias in a conscious canine model of sudden death.
Venkatesh N; Lynch JJ; Uprichard AC; Kitzen JM; Singh BN; Lucchesi BR
J Cardiovasc Pharmacol; 1991 Nov; 18(5):703-10. PubMed ID: 1723767
[TBL] [Abstract][Full Text] [Related]
8. Antiarrhythmic and electrophysiologic actions of CK-3579 and sematilide in a conscious canine model of sudden coronary death.
Chi LG; Mu DX; Driscoll EM; Lucchesi BR
J Cardiovasc Pharmacol; 1990 Aug; 16(2):312-24. PubMed ID: 1697389
[TBL] [Abstract][Full Text] [Related]
9. Prevention of ventricular fibrillation by dextrorotatory sotalol in a conscious canine model of sudden coronary death.
Lynch JJ; Coskey LA; Montgomery DG; Lucchesi BR
Am Heart J; 1985 May; 109(5 Pt 1):949-58. PubMed ID: 3993529
[TBL] [Abstract][Full Text] [Related]
10. The antifibrillatory actions of UK-68,798, a class III antiarrhythmic agent.
Black SC; Chi LG; Mu DX; Lucchesi BR
J Pharmacol Exp Ther; 1991 Aug; 258(2):416-23. PubMed ID: 1865349
[TBL] [Abstract][Full Text] [Related]
11. Cardiac electrophysiologic effects of alinidine, a specific bradycardic agent, in the conscious dog: plasma concentration-response relations.
Boucher M; Chassaing C; Chapuy E
J Cardiovasc Pharmacol; 1995 Feb; 25(2):229-33. PubMed ID: 7752648
[TBL] [Abstract][Full Text] [Related]
12. Vagal stimulation and prevention of sudden death in conscious dogs with a healed myocardial infarction.
Vanoli E; De Ferrari GM; Stramba-Badiale M; Hull SS; Foreman RD; Schwartz PJ
Circ Res; 1991 May; 68(5):1471-81. PubMed ID: 2019002
[TBL] [Abstract][Full Text] [Related]
13. Electrophysiology and antiarrhythmic actions of E-4031 in the experimental animal model of sudden coronary death.
Chi LG; Mu DX; Lucchesi BR
J Cardiovasc Pharmacol; 1991 Feb; 17(2):285-95. PubMed ID: 1709234
[TBL] [Abstract][Full Text] [Related]
14. Antidysrhythmic actions of meobentine sulfate.
Zimmerman JM; Patterson E; Pitt B; Lucchesi B
Am Heart J; 1984 Jun; 107(6):1117-24. PubMed ID: 6720538
[TBL] [Abstract][Full Text] [Related]
15. Prevention of ventricular fibrillation by bretylium in a conscious canine model of sudden coronary death.
Holland K; Patterson E; Lucchesi BR
Am Heart J; 1983 May; 105(5):711-7. PubMed ID: 6846113
[TBL] [Abstract][Full Text] [Related]
16. Electrophysiologic actions and antifibrillatory efficacy of subacute left stellectomy in a conscious, post-infarction canine model of ischemic ventricular fibrillation.
Nelson SD; Lynch JJ; Sanders D; Montgomery DG; Lucchesi BR
Int J Cardiol; 1989 Mar; 22(3):365-76. PubMed ID: 2707916
[TBL] [Abstract][Full Text] [Related]
17. MS-551 protects against ventricular fibrillation in a chronic canine model of sudden cardiac death.
Friedrichs GS; Chi L; Gralinski MR; Black SC; Basler GC; Mu DX; Pewitt SR; Johnson CR; Lucchesi BR
J Cardiovasc Pharmacol; 1995 Feb; 25(2):314-23. PubMed ID: 7752658
[TBL] [Abstract][Full Text] [Related]
18. Ventricular fibrillation in a conscious canine model--its prevention by UM-272.
Eller BT; Patterson E; Lucchesi BR
Eur J Pharmacol; 1983 Mar; 87(4):407-13. PubMed ID: 6852097
[TBL] [Abstract][Full Text] [Related]
19. Effects of pimobendan (UD-CG 115 BS), a new positive inotropic agent, on ventricular tachycardia and ischemic ventricular fibrillation in a conscious canine model of recent myocardial infarction.
Lynch JJ; Kitzen JM; Hoff PT; Lucchesi BR
J Cardiovasc Pharmacol; 1988; 12(5):547-54. PubMed ID: 2468054
[TBL] [Abstract][Full Text] [Related]
20. Antiarrhythmic and electrophysiologic actions of clofilium in experimental canine models.
Kopia GA; Eller BT; Patterson E; Shea MJ; Lucchesi BR
Eur J Pharmacol; 1985 Oct; 116(1-2):49-61. PubMed ID: 4054216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
